Basecamp Wealth Advisors’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Basecamp Wealth Advisors's RXST Position: Q2 2026 in Review
Basecamp Wealth Advisors reduced its RxSight (RXST) stake by 47% in Q2 2026, selling an estimated $537 and leaving 100 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #1640.
Basecamp Wealth Advisors first reported a position in RXST in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.16K in Q1 2026. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- Basecamp Wealth Advisors held 100 shares of RxSight worth $482 as of Q2 2026.
- Basecamp Wealth Advisors sold 89 RxSight shares in Q2 2026, an estimated $537.
- RxSight made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1640 holding.
- Basecamp Wealth Advisors first reported a position in RxSight in Q4 2025 and has held it in 3 quarters since.
- Basecamp Wealth Advisors's RxSight position peaked at $1.16K in Q1 2026.
- 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.